YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Illumina, BGI Battle Over Complete Genomics


November 27, 2012 | The fight for Complete Genomics is not over. BGI and Illumina have both submitted letters arguing that their offer is a better fit to the Complete Genomics board. Illumina has offered a better price, and pointed out that an Illumina-Complete Genomics deal would not be subject to foreign investment oversight. BGI accused Illumina of being anticompetitive and making false allegations. Nature News
View Next Related Story
Illumina at EmTech | Sep 25, 2014
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.